Today, the Nordic region’s largest partnering conference for life sciences has began – come by our stand, B17, or grap a copy of our most recent issue!

Interest in Nordic Life Science Days continues to grow. “Every year, we set a new attendance record,” says Olivier Duchamp, director general of Nordic Life Science Days (NLSDays) . “Five years ago it was 650 attendees; last year it was 1 300.”

Among the Big Pharma, investors and other major players registered for the meeting so far are AstraZeneca, MSD, Pfizer, Sanofi, SOBI, Boehringer Ingelheim, Roche, Bristol-Mayer Squibb, Bayer, Novo, Johnson & Johnson Innovation, GE Healthcare, DNB, Industrifonden, HealthCap, BioGeneration Ventures, Almi Invest, Gilde Healthcare, Gimv, Lundbeckfonden Ventures, Seventure Partners, IBM and IQVIA.

Nine Super Sessions

The super sessions of this year’s NLSDays are zooming in on several potential solutions to some of healthcare’s major challenges. International experts will share their insight and views when it comes to new types of treatments and preventive measures governed by innovations within e.g. digital solutions, big data, artificial intelligence, immune-oncology, drug-delivery and nano- and other technologies. Furthermore, this year’s super sessions also discuss alternative ways for financing projects, ensuring patient engagement and defining the roles of stakeholders when introducing personalized medicine concepts.

The super sessions are: Financing, Return on Engagement, CrossRoads in BioPharma and HealthTech, Precision Medicine, Drug Delivery of the Future, International Investors Pitching, Reproductive Medicine, Catching the Immuno-oncology wave and Artificial Intelligence in Life Science.

Come and litsen to what the largest Nordic life science media channel can do for you and your organization. Welcome to stand B17 at NLSDays on September 10-12 at Stockholm Waterfront.

Read also:

https://nordiclifescience.org/investment-opportunities-and-a-perfect-arena-for-networking/